Latin America Advanced Cancer Diagnostics Market Size & Outlook

The advanced cancer diagnostics market in Latin America is expected to reach a projected revenue of US$ 6,689.0 million by 2033. A compound annual growth rate of 7.9% is expected of Latin America advanced cancer diagnostics market from 2025 to 2033.
Revenue, 2024 (US$M)
$3,363.0
Forecast, 2033 (US$M)
$6,689.0
CAGR, 2025 - 2033
7.9%
Report Coverage
Latin America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America advanced cancer diagnostics market, 2021-2033 (US$M)

Latin America advanced cancer diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America advanced cancer diagnostics market highlights

  • The Latin America advanced cancer diagnostics market generated a revenue of USD 3,363.0 million in 2024.
  • The market is expected to grow at a CAGR of 7.9% from 2025 to 2033.
  • In terms of segment, tumor marker tests was the largest revenue generating test in 2024.
  • Tumor Marker Tests is the most lucrative test segment registering the fastest growth during the forecast period.


Latin America data book summary

Market revenue in 2024USD 3,363.0 million
Market revenue in 2033USD 6,689.0 million
Growth rate7.9% (CAGR from 2025 to 2033)
Largest segmentTumor marker tests
Fastest growing segmentTumor Marker Tests
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTumor Marker Tests
Key market players worldwideRoche Diagnostics, Thermo Fisher Scientific Inc, Illumina Inc, Siemens Healthineers AG ADR, GE HealthCare Technologies Inc Common Stock, Philips, Canon Medical Systems Corp., FUJIFILM Holdings Corp, Agilent Technologies Inc, Bruker Corp, Becton Dickinson and Company, Bio-Rad Laboratories Inc, Myriad Genetics Inc


Other key industry trends

  • In terms of revenue, Latin America region accounted for 5.8% of the global advanced cancer diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 32,732.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Advanced Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website
Roche Diagnostics View profile - - -
Becton Dickinson and Company View profile - - -
Canon Medical Systems Corp. View profile - - -
Philips View profile 10001+ Amsterdam, Noord-Holland, The Netherlands, Europe https://www.usa.philips.com
Bruker Corp View profile 9707 40 Manning Road, Billerica, MA, United States, 01821 https://www.bruker.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
FUJIFILM Holdings Corp View profile 83784 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 http://www.fujifilmholdings.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

Latin America advanced cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to advanced cancer diagnostics market will help companies and investors design strategic landscapes.


Tumor marker tests was the largest segment with a revenue share of 108.59% in 2024. Horizon Databook has segmented the Latin America advanced cancer diagnostics market based on tumor marker tests covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Latin America advanced cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America advanced cancer diagnostics market databook

  • Our clientele includes a mix of advanced cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America advanced cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America advanced cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online